These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7523237)

  • 81. Quantitative in vivo assay of human granulocyte colony-stimulating factor using cyclophosphamide-induced neutropenic mice.
    Hattori K; Shimizu K; Takahashi M; Tamura M; Oheda M; Ohsawa N; Ono M
    Blood; 1990 Mar; 75(6):1228-33. PubMed ID: 1690032
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effects of Prophylactic Administration of Granulocyte Colony-Stimulating Factor on Peripheral Leukocyte and Neutrophil Counts Levels After Chemotherapy in Patients With Early-Stage Breast Cancer: A Retrospective Cohort Study.
    Tian W; Wang Y; Zhou Y; Yao Y; Deng Y
    Front Oncol; 2022; 12():777602. PubMed ID: 35547875
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Application of CSF to cancer treatment].
    Takaku F
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):739-46. PubMed ID: 2455478
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
    Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y; Ohe Y
    Eur J Cancer; 1994; 30A(2):188-94. PubMed ID: 7512356
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Recombinant human granulocyte colony-stimulating factor accelerates regeneration after T-2 toxin-induced hemopoietic injury and lessens lethality in mice.
    Ohtani K; Nanya T; Aoyama Y; Matsunami S; Sekijima M; Kawamura O; Ohtsubo K; Ueno Y
    J Toxicol Sci; 1993 Aug; 18(3):155-66. PubMed ID: 7504113
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer.
    Li W; Dong M; Huang S; Shi L; Yang H; Zhang Y; Gong J; Shi M; Wei L; Zhao L
    Biomol Biomed; 2023 Mar; 23(2):310-316. PubMed ID: 36300280
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A clinical study of polyethylene glycol recombinant human granulocyte colony-stimulating factor prevention neutropenia syndrome in patients with esophageal carcinoma and lung cancer after concurrent chemoradiotherapy.
    Liu F; Du Y; Cai B; Yan M; Yang W; Wang Q
    J Cancer Res Ther; 2017; 13(5):790-795. PubMed ID: 29237905
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of recombinant bovine granulocyte colony-stimulating factor covalently bound to polyethylene glycol injection on neutrophil number and function in periparturient dairy cows.
    Kimura K; Goff JP; Canning P; Wang C; Roth JA
    J Dairy Sci; 2014; 97(8):4842-51. PubMed ID: 24881799
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Mechanism of protective effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on Pseudomonas infection.
    Matsumoto M; Tamura M; Matsubara S; Matsuno T; Ono M; Yokota T
    Microbiol Immunol; 1991; 35(6):461-74. PubMed ID: 1717812
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Separation and purification of PEGylated rhG-CSF by two-step ion-exchange chromatography].
    Chen T; Yun Q; Bi JX; Ma GH; Su ZG
    Sheng Wu Gong Cheng Xue Bao; 2005 Mar; 21(2):284-8. PubMed ID: 16013491
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b.
    Calderwood S; Kilpatrick L; Douglas SD; Freedman M; Smith-Whitley K; Rolland M; Kurtzberg J
    Blood; 2001 Jan; 97(2):376-82. PubMed ID: 11154211
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Granulocyte colony-stimulating factor (GCSF) fused with Fc Domain produced from E. coli is less effective than Polyethylene Glycol-conjugated GCSF.
    Do BH; Kang HJ; Song JA; Nguyen MT; Park S; Yoo J; Nguyen AN; Kwon GG; Jang J; Jang M; Lee S; So S; Sim S; Lee KJ; Osborn MJ; Choe H
    Sci Rep; 2017 Jul; 7(1):6480. PubMed ID: 28744022
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inductive potential of recombinant human granulocyte colony-stimulating factor to mature neutrophils from x-irradiated human peripheral blood hematopoietic progenitor cells.
    Katsumori T; Yoshino H; Hayashi M; Takahashi K; Kashiwakura I
    Biol Pharm Bull; 2009 Nov; 32(11):1849-53. PubMed ID: 19881296
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
    Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The development of bone changes induced in rats by recombinant human granulocyte colony-stimulating factor is suppressed by bisphosphonate.
    Suzuki M; Adachi K; Sugimoto T; Nakayama H; Doi K
    Histol Histopathol; 1999 Jul; 14(3):679-86. PubMed ID: 10425535
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation.
    MacVittie TJ; Monroy RL; Patchen ML; Souza LM
    Int J Radiat Biol; 1990 Apr; 57(4):723-36. PubMed ID: 1691255
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on allogeneic bone marrow transplantation in mice.
    Fukuhara N; Ohnishi N; Mori T; Ozawa A
    Tokai J Exp Clin Med; 1990 May; 15(2-3):261-2. PubMed ID: 1718058
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
    Ema H; Suda T; Sakamoto S; Tomonaga T; Tsunoda J; Muroi K; Komatsu N; Miwa A; Ohsaka A; Yoshida M
    Jpn J Cancer Res; 1989 Jun; 80(6):577-82. PubMed ID: 2474526
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Efficacy of recombinant human granulocyte colony stimulating factor in very-low-birth-weight infants with early neutropenia.
    Teng RJ; Wu TJ; Sharma R; Garrison RD; Hudak ML
    J Formos Med Assoc; 2015 Feb; 114(2):174-9. PubMed ID: 25678180
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Recombinant human granulocyte colony-stimulating factor promotes wound healing in a patient with congenital neutropenia.
    Besner GE; Glick PL; Karp MP; Wang WC; Lobe TE; White CR; Cooney DR
    J Pediatr Surg; 1992 Mar; 27(3):288-90; discussion 291. PubMed ID: 1380074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.